China’s plasma collection was 5,800 tons in 2015. The overall demand needed by the country is predicted to be at 12,000 tons. The blood products market in China is primarily driven by the geriatric populace in need of blood transfusions. Other factors include surgeries involving chronic diseases such as cancer.
A major factor thwarting progress of the market is the lack of blood centers. Red blood cells have a lifespan of 42 days, while platelets have 5 day lifetime. This factor could also be the panic related to 1980s when one of the blood samples provided was found to be HIV-positive. Since then blood drives are done more cautiously at colleges, healthcare centers, and donations. The market is expected to display growth over the forecast period (2018-2023).
The report “Blood Products Markets in China” is available now at http://www.radiantinsights.com/research/blood-products-markets-in-china
Products encompassed in the market are human albumin, Tetanus immunoglobulin, Human rabies immunoglobulin, Human Immunoglobulin (pH4) for Intravenous Injection, Hepatitis B Immunoglobulin, Human Prothrombin Complex, Blood Coagulation Factor VIII, and human immunoglobulin.
Out of these, human blood coagulation factor VIII sold almost 530,000 bottles in 2013. It has garnered nearly 45% market shares by growing annually. Human albumin had a demand of 14.3 million bottles in the same year. Fibrinogen and human blood coagulation factor VIII grew over 50% on a yearly basis. Government initiatives encouraging market growth are currently involved in constructing blood plasma stations.
Request a Free Sample Copy of this Report @ http://www.radiantinsights.com/research/blood-products-markets-in-china/request-sample
Prominent vendors in China’s blood products market are Asahi Kasei Medical Co. Ltd., Shanghai RAAS (Rare Antibody Antigen Supply Inc.) Blood Products Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., and Beijing Tiantan Biological Products, Ltd.
Mergers & acquisitions are a key strategy adopted by market players to expand their reach. Companies with less than 6 types of blood related products are not allowed to set up plasmapheresis centers. Thus, these companies have resorted to buying stake in smaller startups. For instance, Shanghai RAAS bought Zhengzhou Banghe Pharmaceutical in 2013.
Read more related reports by Radiant Insights:
- Tuberculosis Treatment Drugs Market- http://www.radiantinsights.com/research/tuberculosis-treatment-drugs-markets-in-china
China’s demand for Tuberculosis Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
- Digestive Remedies Market- http://www.radiantinsights.com/research/digestive-remedies-markets-in-china
China’s demand for Digestive Remedies has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
About Radiant Insights, Inc
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
For more information or any query mail at firstname.lastname@example.org